welcome
The Motley Fool

The Motley Fool

Health

Health

Down 61%, Is Novo Nordisk Stock Worth Buying on the Dip?

The Motley Fool
Summary
Nutrition label

77% Informative

Danish biotech giant faces scrutiny over its positioning in GLP-1 receptor agonists, as competition intensifies.

Despite strong growth and earnings momentum, the company's fundamental strengths make it worth a closer look.

Novo Nordisk currently offers both a 2.7% dividend and compelling value that can work well within a diversified portfolio.

The Motley Fool Stock Advisor analyst team identified what they believe are the 10 best stocks for investors to buy now and Novo Nordisk wasn’t one of them.

The 10 stocks that made the cut could produce monster returns in the coming years .

Consider when Netflix made this list on December 17, 2004 ... if you invested $ 1,000 at the time of our recommendation, you’d have $ 524,747 !.

Small business owner?

Otherweb launches Autoblogger—a revolutionary way to bring more leads to any small business, using the power of AI.